The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

On February 28, investors will get the January reading of the Personal Consumption Expenditure (PCE) index. Spoiler alert: it ...

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...

This $1M diversification strategy uses top ETFs and firms to reduce risk. Find out how combining growth, dividends, and ...

We are currently undergoing maintenance on some services, which may temporarily affect access to subscription accounts and ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other best vaccine stocks to buy now. What Will Trump’s Tariffs Mean for the Pharma Industry?

RAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Tuesday reported fourth-quarter net income of $3.74 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...